Description of cellular lines in peripheral blood with blasts in different regions of Colombia, 2017. Case series
DOI:
https://doi.org/10.17533/udea.iatreia.50Keywords:
anemia, blood cells, leukocytes, leukemia, thrombocytopeniaAbstract
Introduction: Leukemia constitutes a complex group of haemopathies, which due to their etiology, pathogenesis and mortality, can be considered a public health problem. Its early detection allows for timely remission for confirmation of the diagnosis and early start of treatment.
Objective: To describe the sanguineous cellularity in a population with presence of blasts in peripheral blood coming from different regions of Colombia during the year 2017.
Methods: A descriptive study, type case series. Hemograms and peripheral blood smears from patients with blast presence or a presumptive diagnosis of leukemia were analyzed in five cities of Colombia, all of whom met the inclusion criteria.
Results: 39 patients with presence of de novo blasts from Cúcuta 48.7%, Valledupar 33.3%, Tunja 10.3%, Socorro 5.1% and Villavicencio 2.6% were found. All the individuals were affiliated to the Colombian healthcare system. Fifty four percent of the subjects were female, with an average age of 44.2 years for men and 32.5 for women. Seventy six percent of the patients presented moderate to severe leukocytosis and 69.2% neutropenia. Ninety-five percent had anemia, 51% hypochromia and 38% microcytes, 74% presented thrombocytopenia and 15% macroplates.
Conclusions: These findings are a match to those found in the literature, as for the predominance of the disease by age and sex. Anemia, thrombocytopenia and neutropenia are a set of characteristics that remain constant in patients with leukemia.
Downloads
References
(1) Instituto Nacional de Salud. Informe final vigilancia: leucemia en menores de 15 años 2013 [internet].[Consultado 2018 sep 2]. Disponible en: http://cort.as/-SjpG
(2) Instituto Nacional de Salud. Primer Informe ONS: observatorio nacional del Salud ONS, aspectos relacionados con la frecuencia de uso de los servicios de salud, mortalidad y discapacidad en Colombia, 2011 [internet]. [Consultado 2018 oct 5]. Disponible en: http://cort.as/-SjpZ
(3) Vera AM, Pardo C, Duarte MC, Suárez A. Experiencia en el análisis de la mortalidad por leucemia aguda pediátrica en el Instituto Nacional de Cancerología. Biomédica. 2012 Mar 13;32(3):355–64. DOI 10.7705/biomedica.v32i3.691.
(4) Villalba-Toquica C, Martínez Silva PA, Acero H. Caracterización Clinico-Epidemiologica de los pacientes pediátricos con Leucemias agudas en la Clínica Universitaria Colombia. Serie de Casos 2011-2014. Pediatría. 2016 January-March;49(1):17-22. DOI 10.1016/j.rcpe.2016.01.002.
(5) Rendón-Macías ME, Reyes-Zepeda NC. Supervivencia en niños con leucemia; un gran reto para nuestra sociedad contemporánea. Rev. mex. pediatr. 2017. Noviembre-Diciembre;84(6):213-5.
(6) Colombia. Instituto Nacional de Cancerología. 2017. Guía Práctica Clínica para la detección, tratamiento y seguimiento de leucemias linfoblástica y mieloide en población mayor de 18 años [internet]. [Consultado 2018 nov 27]. Disponible en: http://cort.as/-Sjtb
(7) Mudireddy M, Gangat N, Hanson CA, Ketterling RP, Pardanani A, Tefferi A. Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis. Blood Cancer J. 2018 Jun;8(6):57. DOI 10.1038/s41408-018-0095-2.
(8) Jaime-Pérez JC, García-Arellano G, Herrera-Garza JL, Marfil-Rivera LJ, Gómez-Almaguer D. Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center. Hematol Transfus Cell Ther. 2019 Jan-Mar;41(1):57-61. DOI 10.1016/j.htct.2018.05.010.
(9) Santoyo-Sánchez A, Ramos-Peñafiel CO, Saavedra-González A, González-Almanza L, Martínez-Tovar A, Olarte-Carrillo I, et al. Frecuencias de edad y género de pacientes con leucemia observada en dos centros de referencia del Valle de México. Gac. Méd. Mex. 2016;152:208–12.
(10) Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-92.
(11) Arber DA, Orazi A, HasserjianR, Thiele J, Borowitz MJ, Le Beau et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391-405. DOI 10.1182/blood-2016-03-643544.
(12) Pita AMS, Hernández-Rego Y, Bencomo-Hernández A, Cabrales-Fonseca S. Hallazgos en el hemograma de debut de pacientes con leucemia mieloide aguda. Rev. cuba. hematol. immunol. hemoter. 2017;33(S1):1–4.
(13) Lassaletta-Atienza A. Leucemias. Leucemia linfoblástica aguda. Pediatr Integral. 2016;20(6):380–9.
Vizcaíno M, Lopera J, Martínez L, De los Reyes L, Linares A, Guía de atención integral para la detección oportuna, diagnóstico, tratamiento y seguimiento de leucemia linfoide aguda en niños, niñas y adolescentes. Rev Colomb Cancerol. 2016;20(1):17-27. DOI 10.1016/j.rccan.2015.08.003.
(15) Greer JP, Arber D, Glader B, List AF, Means RT Jr, Paraskevas F, et al. Wintrobe’s Clinical Hematology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
(16) Jiménez de Samudio A, Samudio M, Caniza MA. Risk Factors associated to survival in children and adolescent
with Acute Lymphoblastic Leukemia. Pediatría. Pediatr. (Asunción). 2016;43(1). DOI 10.18004/ped.2016.abril.18-26.
(17) Jaime-Pérez JC, García-Arellano G, Herrera-Garza JL, Marfil-Rivera LJ, Gómez-Almaguer D. Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center. Hematol Transfus cell Ther. 2019 Jan-Mar;41(1):57-61. DOI 10.1016/j.htct.2018.05.010.
(18) Linet MS, Brown LM, Mbulaiteye SM, Check D, Ostroumova E, Landgren A, et al. International longterm trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer. 2016 Apr 15;138(8):1862-74. DOI 10.1002/ijc.29924.
(19) Leukemia-Net. 2013 [internet]. Europa: ELN leukemia; 2003. [Cited 2018 Nov 22]. Available from: http://cort.as/-TkZE
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Universidad de Antioquia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
